Profile data is unavailable for this security.
About the company
YABAO PHARMACEUTICAL GROUP CO. LTD is a China-based company, principally engaged in the research and development, production and distribution of pharmaceuticals. The Company mainly provides light pastes, tablets, injections, capsules, oral liquids, bulk drugs and other pharmaceutical products. The Company is also engaged in the wholesaling and trading of pharmaceuticals. The Company distributes its products within domestic market and to overseas markets.
- Revenue in CNY (TTM)2.88bn
- Net income in CNY204.43m
- Incorporated1999
- Employees4.14k
- LocationYabao Pharmaceutical Group Co LtdNo.1Gongye BoulevardFenglingdu Economic Development ZoneBEIJING 100176ChinaCHN
- Phone+86 1 057809936
- Fax+86 1 057809937
- Websitehttp://www.yabao.com.cn/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hangzhou Alltest Biotech Co Ltd | 718.48m | 184.83m | 4.55bn | 1.09k | 24.68 | 1.16 | -- | 6.34 | 2.33 | 2.33 | 9.02 | 49.43 | 0.165 | 2.13 | 6.17 | 657,349.00 | 4.24 | 23.35 | 4.57 | 26.83 | 46.83 | 58.34 | 25.69 | 39.07 | 10.16 | -- | 0.0056 | 29.79 | -77.73 | 32.59 | -84.75 | 26.19 | 72.77 | -- |
| Yabao Pharmaceutical Group Co Ltd | 2.88bn | 204.43m | 4.72bn | 4.14k | 23.82 | 1.62 | -- | 1.64 | 0.2754 | 0.2754 | 3.81 | 4.05 | 0.7193 | 2.98 | 6.79 | 695,432.10 | 4.52 | 2.82 | 5.90 | 3.97 | 56.00 | 59.20 | 6.29 | 4.19 | 1.62 | 47.13 | 0.0675 | 43.74 | 7.05 | -0.0572 | 90.71 | -6.10 | 7.98 | -9.71 |
| Hainan Huluwa Pharmaceutical Grop Co Ltd | 1.81bn | 94.97m | 4.73bn | 2.47k | 49.84 | 4.12 | -- | 2.62 | 0.2374 | 0.2374 | 4.52 | 2.87 | 0.6721 | 2.88 | 3.81 | 732,708.90 | 3.80 | 5.81 | 6.29 | 9.78 | 50.33 | 58.01 | 5.66 | 7.03 | 0.8245 | 7.04 | 0.5246 | 21.74 | 25.75 | 14.13 | 24.29 | 1.16 | 46.37 | -- |
| GemPharmatech Co Ltd | 638.97m | 157.34m | 4.78bn | 1.51k | 30.36 | 2.24 | -- | 7.48 | 0.3838 | 0.3838 | 1.56 | 5.20 | 0.2617 | 4.11 | 2.36 | 424,282.40 | 6.44 | 9.45 | 7.28 | 11.13 | 66.43 | 70.21 | 24.62 | 28.16 | 4.68 | -- | 0.0592 | 14.68 | 20.45 | 63.48 | -3.48 | -- | 141.38 | -- |
| Shanghai Haoyuan Chemexpress Co Ltd | 1.97bn | 97.97m | 4.78bn | 3.37k | 48.72 | 1.88 | -- | 2.43 | 0.652 | 0.652 | 13.10 | 16.92 | 0.4845 | 1.01 | 3.91 | 583,547.80 | 2.38 | 7.38 | 3.23 | 9.60 | 42.51 | 47.03 | 4.92 | 13.53 | 0.894 | 3.37 | 0.3013 | 14.37 | 38.44 | 44.33 | -34.18 | 47.24 | 48.95 | -- |
| Getein Biotech Inc | 1.31bn | 244.26m | 4.79bn | 2.14k | 19.60 | 1.81 | -- | 3.66 | 0.4816 | 0.4816 | 2.58 | 5.22 | 0.3502 | 1.61 | 2.77 | 611,337.70 | 6.63 | 13.25 | 9.24 | 18.45 | 66.13 | 65.57 | 18.92 | 28.13 | 1.97 | -- | 0.1857 | 29.88 | -24.85 | 14.81 | -43.92 | 2.31 | 18.44 | 6.00 |
| Shanghai Medicilon Inc | 1.17bn | -172.33m | 4.81bn | 2.60k | -- | 1.95 | -- | 4.10 | -1.24 | -1.24 | 9.11 | 18.34 | 0.4205 | 6.63 | 1.64 | 451,437.20 | -6.17 | 9.34 | -7.97 | 11.73 | 12.48 | 36.71 | -14.68 | 14.93 | 2.63 | -- | 0.1229 | 20.18 | -17.68 | 33.26 | -109.82 | -- | 23.60 | -- |
| Beijing Konruns Pharmaceutical Co Ltd | 954.14m | 166.44m | 4.89bn | 447.00 | 28.86 | 1.55 | -- | 5.13 | 1.06 | 1.06 | 6.05 | 19.78 | 0.2548 | 2.50 | 3.73 | 2,134,547.00 | 5.46 | 5.43 | 6.39 | 6.24 | 88.29 | 89.93 | 21.44 | 20.76 | 3.08 | -- | 0.0486 | 21.53 | 6.15 | -2.08 | 48.24 | -10.63 | 43.05 | -9.71 |
Data as of May 17 2024. Currency figures normalised to Yabao Pharmaceutical Group Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
4.82%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| GF Fund Management Co., Ltd.as of 30 Jun 2023 | 11.86m | 1.54% |
| China Merchants Fund Management Co., Ltd.as of 30 Jun 2023 | 8.09m | 1.05% |
| Broad Fund Management Co. Ltd.as of 30 Jun 2023 | 5.17m | 0.67% |
| China Universal Asset Management Co., Ltd.as of 30 Jun 2023 | 3.51m | 0.46% |
| The Vanguard Group, Inc.as of 31 Mar 2024 | 2.47m | 0.32% |
| Penghua Fund Management Co., Ltd.as of 30 Jun 2023 | 1.54m | 0.20% |
| Hwabao WP Fund Management Co., Ltd.as of 30 Jun 2023 | 1.43m | 0.19% |
| Gfund Management Co., Ltd.as of 30 Jun 2023 | 1.33m | 0.17% |
| China Post & Capital Fund Management Co., Ltd.as of 30 Jun 2023 | 1.29m | 0.17% |
| Great Wall Fund Management Co., Ltd.as of 30 Jun 2023 | 424.30k | 0.06% |
More ▼
Data from 30 Jun 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
